A whole slew of next-generation obesity drugs are on the horizon, some already advanced enough in clinical trials to be looking as good as-if not better than-those already on the market. The novel medications continue to push the upward limits of weight loss, now to almost 25 percent of body weight on average, but they also differ in their modes of action. They target different cells and different parts of cells in the brain and body.
And when any White House experiences a humiliating defeat. And believe me, I've been part of those, the instinct is often most of the time to change the subject. I mean, roll out a new policy, hold a big event, make any announcement of any kind, basically to get people to talk about anything other than the absolute shellacking that you just took at the polls.